Saturday, January 27, 2024
The partnership between A.D.A.M. (Advanced Development of Additive Manufacturing) and the Icahn School of Medicine at Mount Sinai in New York, NY, signals a significant advancement in healthcare technology. Together, they aim to revolutionize bone implant delivery and the development of soft tissue medical devices by merging A.D.A.M.'s expertise in 3D printing systems for customized bone implants with Mount Sinai BioDesign's proficiency in medical device innovation.
This collaboration entails technological fusion, wherein A.D.A.M.'s cutting-edge 3D printing technology will be integrated to enhance the production of personalized bone implants. By combining advanced manufacturing processes with medical device innovation, the partnership seeks to elevate patient care standards.
Furthermore, the collaboration will prioritize research and development efforts to refine 3D printed bone tissues. Through the utilization of A.D.A.M.'s technology and Mount Sinai BioDesign's specialized knowledge, the partnership aims to push the boundaries of bone implant delivery.
The formation of the "Soft Tissues Working Group" underscores a shared commitment to exploring the potential of 3D printing in soft tissue medical devices. This initiative reflects their joint dedication to addressing healthcare challenges through interdisciplinary collaboration.
At its core, the collaboration aims to improve patient care within the healthcare sector. By leveraging technological innovation and medical expertise, A.D.A.M. and Mount Sinai BioDesign aspire to develop solutions that effectively address critical healthcare needs and enhance patient outcomes.
Through this collaborative effort, A.D.A.M. and the Icahn School of Medicine at Mount Sinai demonstrate their mutual commitment to advancing healthcare through innovation and partnership. By pooling their resources and expertise, they seek to make meaningful contributions to medical technology and patient care.
Source: prnewswire.com
